This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Cardiovascular System  • Radiologic Imaging  • Renal Diseases  • Acute Renal Failure  • Angiology  • Cardiac Diagnostic Tests  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Kay and colleagues¹ found that in patients with moderate renal insufficiency undergoing coronary angiography, prophylactic use of acetylcysteine with hydration resulted in an 8% absolute risk reduction in the incidence of contrast-induced nephropathy. Despite promising results from additional similar trials with acetylcysteine,^2-3 we are concerned about how the primary end point was defined in this study.

Like other authors,^4-5 Kay et al defined contrast-induced nephropathy as a 25% increase in serum creatinine level, a definition that has traditionally been used as a surrogate end point for reduction in kidney function. It is unclear, however, whether this reflects other clinically important end points such as need for dialysis, length of hospitalization, or mortality.⁶ The study by Kay et al was not designed to detect these as primary outcomes, despite the finding of a half-day reduction in length of hospitalization and that no patient required dialysis. Therefore, we . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Theophylline for Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis
Bagshaw and Ghali
Arch Intern Med 2005;165:1087-1093.
ABSTRACT | FULL TEXT